A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer

Background: We evaluated the efficacy and safety of gemcitabine in combination with erlotinib and S-1 for the treatment of advanced pancreatic cancer. Methods: Chemotherapy-naïve patients with pathologically-proven locally advanced, recurrent, or metastatic pancreatic adenocarcinoma were assessed fo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cancer
Hlavní autoři: Han, Boram, Kim, Bum Jun, Kim, Hyeong Su, Choi, Dae Ro, Shim, Byoung Yong, Lee, Kyung Hee, Kim, Jin Won, Kim, Jung Han, Song, Hunho, Kim, Jong Hyeok, Park, Choong Kee, Lee, Jung Woo, Kim, Min-Jeong, Zang, Dae Young
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2021
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7778528/
https://ncbi.nlm.nih.gov/pubmed/33403047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.50514
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky